Related Experiment Video
Updated: Jun 21, 2026

Real-Time, Semi-Automated Fluorescent Measurement of the Airway Surface Liquid pH of Primary Human Airway Epithelial Cells
Published on: June 13, 2019
Early phosphate changes as potential indicator of unreadiness for artificial feeding: a secondary analysis of the
C Lauwers1, L Langouche1, P J Wouters1
1Clinical Division and Laboratory of Intensive Care Medicine, Department of Cellular and Molecular Medicine, KU Leuven, 3000, Leuven, Belgium.
Insights
Relative hypophosphatemia (RHP), a significant drop in phosphate levels, identifies critically ill patients harmed by early parenteral nutrition (PN). Early PN worsened outcomes in RHP patients, highlighting RHP as a potential indicator for tailored nutritional strategies in the ICU.
Area of Science:
- Critical Care Medicine
- Nutritional Support
- Clinical Chemistry
Background:
- Early parenteral nutrition (PN) in the ICU prolonged dependency compared to delayed PN in the EPaNIC trial.
- Refeeding hypophosphatemia (a phosphate decrease > 0.16 mmol/L to < 0.65 mmol/L) in ICU patients can be managed with temporary macronutrient restriction.
- This study investigates if early dynamic phosphate changes, not just absolute levels, predict harm from early PN.
Purpose of the Study:
- To determine if absolute hypophosphatemia (AHP), relative hypophosphatemia (RHP), or combined hypophosphatemia (CHP) interacts with early PN's impact on patient outcomes.
- To assess if RHP can identify critically ill patients negatively affected by early PN.
Main Methods:
- Secondary analysis of the EPaNIC randomized controlled trial (RCT) involving 3520 patients.
- Defined AHP (< 0.65 mmol/L on day 2), RHP (> 0.16 mmol/L decrease in first 2 days), and CHP.
- Examined interactions between hypophosphatemia types and early PN strategy, adjusting for risk factors.
Main Results:
- RHP occurred in 23.7% of patients and significantly interacted with the nutritional strategy (p=0.01).
- In RHP patients, early PN was associated with lower likelihood of earlier ICU discharge alive (aHR 0.75).
- Early PN showed no significant association with outcome in non-RHP patients (aHR 0.93); RHP was poorly predicted by baseline characteristics.
Conclusions:
- Development of RHP may identify ICU patients harmed by early PN administration.
- RHP could serve as a potential indicator for personalized nutritional strategies in critically ill patients.
- Prospective studies are needed to validate RHP's utility as a ready-to-feed indicator.
Background:
As compared to withholding parenteral nutrition (PN) until one week after intensive care unit (ICU) admission, Early PN prolonged ICU dependency in the EPaNIC randomized controlled trial (RCT). The Refeeding RCT showed improved outcome by temporary macronutrient restriction in ICU patients developing refeeding hypophosphatemia, defined as a phosphate decrease of > 0.16 mmol/L to levels < 0.65 mmol/L. We hypothesized that early phosphate changes may identify critically ill patients who are harmed by Early PN, and that dynamic phosphate changes are more discriminative than an absolute threshold for hypophosphatemia.
Methods:
In this secondary analysis of the EPaNIC RCT, we studied whether absolute hypophosphatemia (AHP; < 0.65 mmol/L on the second ICU-day), relative hypophosphatemia (RHP; > 0.16 mmol/L decrease over the first 2 ICU-days), or a combination of both (CHP) interacted with the randomized nutritional strategy for its impact on outcome, adjusted for risk factors. In case of significant interaction, we studied whether the respective change could be predicted by baseline characteristics.
Results:
Of 3520 patients with available phosphate measurements, AHP developed in 9.1%, RHP in 23.7%, and CHP in 5.3% of patients. RHP, but not AHP or CHP, interacted with the randomized intervention for its impact on outcome (p = 0.01). In RHP patients, Early PN independently associated with a lower likelihood of an earlier discharge alive from ICU (adjusted HR 0.75 [0.65-0.87]). In patients without RHP, Early PN did not significantly associate with this outcome (adjusted HR 0.93 [0.86-1.00]). Development of RHP was only poorly predicted by admission characteristics (adjusted pseudo R-squared = 1.7%).
Conclusion:
Development of RHP may identify patients who are particularly harmed by early PN. Future studies should prospectively validate the potential of including RHP in a ready-to-feed indicator.
More Related Videos
08:27Analysis of Effect of Compound Salt Stress on Seed Germination and Salt Tolerance Analysis of Pepper (Capsicum annuum L.)
Published on: November 30, 2022
07:21Separation and Differential Characterization of Gut Microbial Extracellular Vesicles in Salt-Sensitive Rats under High-Salt Diet Conditions
Published on: June 6, 2025
Related Concept Videos
Determining the pH of Salt Solutions
Indicators
Titration of Polyprotic Base with a Strong Acid
Diagnosing Acidosis and Alkalosis
First, the pH level is assessed to determine whether the blood pH is normal (7.35–7.45), low (acidosis), or high (alkalosis).
Next, the PCO2 and HCO3− values are examined to...